192 related articles for article (PubMed ID: 34990836)
1. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase.
Lam UTF; Chen ES
Int J Biochem Cell Biol; 2022 Mar; 144():106155. PubMed ID: 34990836
[TBL] [Abstract][Full Text] [Related]
2. Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation.
Hacker KE; Fahey CC; Shinsky SA; Chiang YJ; DiFiore JV; Jha DK; Vo AH; Shavit JA; Davis IJ; Strahl BD; Rathmell WK
J Biol Chem; 2016 Sep; 291(40):21283-21295. PubMed ID: 27528607
[TBL] [Abstract][Full Text] [Related]
3. Shaping the cellular landscape with Set2/SETD2 methylation.
McDaniel SL; Strahl BD
Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724
[TBL] [Abstract][Full Text] [Related]
4. SETD2: from chromatin modifier to multipronged regulator of the genome and beyond.
Molenaar TM; van Leeuwen F
Cell Mol Life Sci; 2022 Jun; 79(6):346. PubMed ID: 35661267
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional specificity of H3K36 methylation.
Lam UTF; Tan BKY; Poh JJX; Chen ES
Epigenetics Chromatin; 2022 May; 15(1):17. PubMed ID: 35581654
[TBL] [Abstract][Full Text] [Related]
6. Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSĪ± interaction.
Fang J; Huang Y; Mao G; Yang S; Rennert G; Gu L; Li H; Li GM
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9598-9603. PubMed ID: 30181289
[TBL] [Abstract][Full Text] [Related]
7. A New Chromatin-Cytoskeleton Link in Cancer.
Giaccia AJ
Mol Cancer Res; 2016 Dec; 14(12):1173-1175. PubMed ID: 27528705
[TBL] [Abstract][Full Text] [Related]
8. SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.
Fahey CC; Davis IJ
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159833
[TBL] [Abstract][Full Text] [Related]
9. SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.
Gautam D; Johnson BA; Mac M; Moody CA
PLoS Pathog; 2018 Oct; 14(10):e1007367. PubMed ID: 30312361
[TBL] [Abstract][Full Text] [Related]
10. Set2 methyltransferase facilitates cell cycle progression by maintaining transcriptional fidelity.
Dronamraju R; Jha DK; Eser U; Adams AT; Dominguez D; Choudhury R; Chiang YC; Rathmell WK; Emanuele MJ; Churchman LS; Strahl BD
Nucleic Acids Res; 2018 Feb; 46(3):1331-1344. PubMed ID: 29294086
[TBL] [Abstract][Full Text] [Related]
11.
Chiang YC; Park IY; Terzo EA; Tripathi DN; Mason FM; Fahey CC; Karki M; Shuster CB; Sohn BH; Chowdhury P; Powell RT; Ohi R; Tsai YS; de Cubas AA; Khan A; Davis IJ; Strahl BD; Parker JS; Dere R; Walker CL; Rathmell WK
Cancer Res; 2018 Jun; 78(12):3135-3146. PubMed ID: 29724720
[TBL] [Abstract][Full Text] [Related]
12. The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 Pathway.
Mac M; DeVico BM; Raspanti SM; Moody CA
J Virol; 2023 May; 97(5):e0020123. PubMed ID: 37154769
[TBL] [Abstract][Full Text] [Related]
13. SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability.
Pfister SX; Ahrabi S; Zalmas LP; Sarkar S; Aymard F; Bachrati CZ; Helleday T; Legube G; La Thangue NB; Porter AC; Humphrey TC
Cell Rep; 2014 Jun; 7(6):2006-18. PubMed ID: 24931610
[TBL] [Abstract][Full Text] [Related]
14. SETD2 reduction adversely affects the development of mouse early embryos.
Li C; Huang Z; Gu L
J Cell Biochem; 2020 Jan; 121(1):797-803. PubMed ID: 31407364
[TBL] [Abstract][Full Text] [Related]
15. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase SETD2 negatively regulates cell size.
Molenaar TM; Malik M; Silva J; Liu NQ; Haarhuis JHI; Ambrosi C; Kwesi-Maliepaard EM; van Welsem T; Baubec T; Faller WJ; van Leeuwen F
J Cell Sci; 2022 Oct; 135(19):. PubMed ID: 36052643
[TBL] [Abstract][Full Text] [Related]
17. A conserved genetic interaction between Spt6 and Set2 regulates H3K36 methylation.
Gopalakrishnan R; Marr SK; Kingston RE; Winston F
Nucleic Acids Res; 2019 May; 47(8):3888-3903. PubMed ID: 30793188
[TBL] [Abstract][Full Text] [Related]
18. The disordered regions of the methyltransferase SETD2 govern its function by regulating its proteolysis and phase separation.
Bhattacharya S; Lange JJ; Levy M; Florens L; Washburn MP; Workman JL
J Biol Chem; 2021 Sep; 297(3):101075. PubMed ID: 34391778
[TBL] [Abstract][Full Text] [Related]
19. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
Xie Y; Sahin M; Wakamatsu T; Inoue-Yamauchi A; Zhao W; Han S; Nargund AM; Yang S; Lyu Y; Hsieh JJ; Leslie CS; Cheng EH
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810256
[TBL] [Abstract][Full Text] [Related]
20. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
Ho TH; Park IY; Zhao H; Tong P; Champion MD; Yan H; Monzon FA; Hoang A; Tamboli P; Parker AS; Joseph RW; Qiao W; Dykema K; Tannir NM; Castle EP; Nunez-Nateras R; Teh BT; Wang J; Walker CL; Hung MC; Jonasch E
Oncogene; 2016 Mar; 35(12):1565-74. PubMed ID: 26073078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]